{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T14:57:31Z","timestamp":1791644251050,"version":"4.3.4"},"reference-count":176,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Diagn Ther"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s40291-026-00834-9","type":"journal-article","created":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T15:39:54Z","timestamp":1771256394000},"page":"337-360","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The Role of Non-coding RNAs in Connective Tissue Diseases: Diagnostic and Therapeutic Potential of miRNAs, lncRNAs and circRNAs"],"prefix":"10.1007","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0586-0918","authenticated-orcid":false,"given":"Malwina","family":"Botor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolina L.","family":"St\u0119pie\u0144","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolina","family":"Jankowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micha\u0142","family":"Thlon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,16]]},"reference":[{"issue":"3","key":"834_CR1","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.autrev.2012.06.004","volume":"12","author":"L Iaccarino","year":"2013","unstructured":"Iaccarino L, Gatto M, Bettio S, Caso F, Rampudda M, Zen M, et al. Overlap connective tissue disease syndromes. Autoimmun Rev. 2013;12(3):363\u201373. https:\/\/doi.org\/10.1016\/j.autrev.2012.06.004.","journal-title":"Autoimmun Rev"},{"issue":"1","key":"834_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.autrev.2006.03.004","volume":"6","author":"M Mosca","year":"2006","unstructured":"Mosca M, Tani C, Neri C, Baldini C, Bombardieri S. Undifferentiated connective tissue diseases (UCTD). Autoimmun Rev. 2006;6(1):1\u20134. https:\/\/doi.org\/10.1016\/j.autrev.2006.03.004.","journal-title":"Autoimmun Rev"},{"key":"834_CR3","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.30330","author":"MA Ameer","year":"2022","unstructured":"Ameer MA, Chaudhry H, Mushtaq J, Khan OS, Babar M, Hashim T, et al. An overview of systemic lupus erythematosus (SLE) pathogenesis, classification, and management. Cureus. 2022. https:\/\/doi.org\/10.7759\/cureus.30330.","journal-title":"Cureus"},{"issue":"2","key":"834_CR4","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1093\/rheumatology\/key277","volume":"58","author":"AS Zayat","year":"2019","unstructured":"Zayat AS, Mahmoud K, Md Yusof MY, Mukherjee S, D\u2019agostino MA, Hensor EM, et al. Defining inflammatory musculoskeletal manifestations in systemic lupus erythematosus. Rheumatology. 2019;58(2):304\u201312. https:\/\/doi.org\/10.1093\/rheumatology\/key277.","journal-title":"Rheumatology"},{"issue":"4","key":"834_CR5","first-page":"330","volume":"6","author":"M Cojocaru","year":"2011","unstructured":"Cojocaru M, Cojocaru IM, Silosi I, Vrabie CD. Manifestations of systemic lupus erythematosus. Maedica. 2011;6(4):330.","journal-title":"Maedica"},{"issue":"13","key":"834_CR6","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1177\/0961203316642308","volume":"25","author":"M Fawzy","year":"2016","unstructured":"Fawzy M, Edrees A, Okasha H, El Ashmaui A, Ragab G. Gastrointestinal manifestations in systemic lupus erythematosus. Lupus. 2016;25(13):1456\u201362. https:\/\/doi.org\/10.1177\/0961203316642308.","journal-title":"Lupus"},{"key":"834_CR7","doi-asserted-by":"publisher","first-page":"39","DOI":"10.2147\/TCRM.S252592","volume":"17","author":"A Bag-Ozbek","year":"2021","unstructured":"Bag-Ozbek A, Hui-Yuen JS. Emerging B-cell therapies in systemic lupus erythematosus. Ther Clin Risk Manag. 2021;17:39\u201354. https:\/\/doi.org\/10.2147\/TCRM.S252592.","journal-title":"Ther Clin Risk Manag"},{"key":"834_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-382040-2.10019-X","author":"FH Glorieux","year":"2012","unstructured":"Glorieux FH, Rowe D. Osteogenesis imperfecta. Pediatr Bone. 2012. https:\/\/doi.org\/10.1016\/B978-0-12-382040-2.10019-X.","journal-title":"Pediatr Bone."},{"key":"834_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-382040-2.10019-X","author":"R Bronheim","year":"2019","unstructured":"Bronheim R, Khan S, Carter E, Sandhaus RA, Raggio C. Scoliosis and cardiopulmonary outcomes in osteogenesis imperfecta patients. Spine. 2019. https:\/\/doi.org\/10.1016\/B978-0-12-382040-2.10019-X.","journal-title":"Spine"},{"issue":"6","key":"834_CR10","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1002\/ajmg.a.36545","volume":"164","author":"FS Van Dijk","year":"2014","unstructured":"Van Dijk FS, Sillence DO. Osteogenesis imperfecta: clinical diagnosis, nomenclature and severity assessment. Am J Med Genet A. 2014;164(6):1470\u201381. https:\/\/doi.org\/10.1002\/ajmg.a.36545.","journal-title":"Am J Med Genet A"},{"key":"834_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00924","volume":"10","author":"SH Ralston","year":"2020","unstructured":"Ralston SH, Gaston MS. Management of osteogenesis imperfecta. Front Endocrinol. 2020;10:924. https:\/\/doi.org\/10.3389\/fendo.2019.00924.","journal-title":"Front Endocrinol"},{"key":"834_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-18013-x","volume":"15","author":"L Zheng","year":"2025","unstructured":"Zheng L, Baroom G, Naqvi RE, et al. Tobacco smoking and the risk of aortic aneurysm in the UK biobank. Sci Rep. 2025;15:32191. https:\/\/doi.org\/10.1038\/s41598-025-18013-x.","journal-title":"Sci Rep"},{"issue":"3","key":"834_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/ph12030118","volume":"12","author":"EM Maguire","year":"2019","unstructured":"Maguire EM, Pearce SW, Xiao R, Oo AY, Xiao Q. Matrix metalloproteinase in abdominal aortic aneurysm and aortic dissection. Pharmaceuticals. 2019;12(3):118. https:\/\/doi.org\/10.3390\/ph12030118.","journal-title":"Pharmaceuticals"},{"issue":"6","key":"834_CR14","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1016\/j.jvs.2011.06.095","volume":"54","author":"D Koole","year":"2011","unstructured":"Koole D, Moll FL, Buth J, Hobo R, Zandvoort HJ, Bots ML, et al. Annual rupture risk of abdominal aortic aneurysm enlargement without detectable endoleak after endovascular abdominal aortic repair. J Vasc Surg. 2011;54(6):1614\u201322. https:\/\/doi.org\/10.1016\/j.jvs.2011.06.095.","journal-title":"J Vasc Surg"},{"key":"834_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-397165-4.00011-3","author":"B Brodsky","year":"2014","unstructured":"Brodsky B, Persikov A. Structural consequences of glycine missense mutations in osteogenesis imperfecta. Osteogenesis Imperfecta. 2014. https:\/\/doi.org\/10.1016\/B978-0-12-397165-4.00011-3.","journal-title":"Osteogenesis Imperfecta"},{"issue":"2","key":"834_CR16","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/s41580-020-00315-9","volume":"22","author":"L Statello","year":"2021","unstructured":"Statello L, Guo CJ, Chen LL, Huarte M. Gene regulation by long non-coding RNAs and its biological functions. Nat Rev Mol Cell Biol. 2021;22(2):96\u2013118. https:\/\/doi.org\/10.1038\/s41580-020-00315-9.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"6","key":"834_CR17","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1007\/s11011-021-00739-y","volume":"36","author":"GK Bhatti","year":"2021","unstructured":"Bhatti GK, Khullar N, Sidhu IS, Navik US, Reddy AP, Reddy PH, et al. Emerging role of non-coding RNA in health and disease. Metab Brain Dis. 2021;36(6):1119\u201334. https:\/\/doi.org\/10.1007\/s11011-021-00739-y.","journal-title":"Metab Brain Dis"},{"issue":"10","key":"834_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/ph16101414","volume":"16","author":"M Botor","year":"2023","unstructured":"Botor M, Augu\u015bciak-Duma A, Lesiak M, Siero\u0144 \u0141, Dziedzic-Kowalska A, Witecka J, et al. Analysis of miRNAs in osteogenesis imperfecta caused by mutations in COL1A1 and COL1A2: insights into molecular mechanisms and potential therapeutic targets. Pharmaceuticals (Basel). 2023;16(10):1414. https:\/\/doi.org\/10.3390\/ph16101414.","journal-title":"Pharmaceuticals (Basel)"},{"issue":"5","key":"834_CR19","volume":"14","author":"Y Jiang","year":"2021","unstructured":"Jiang Y, Zhao Y, Mo X. Expression of lncRNA NEAT1 in peripheral blood mononuclear cells of patients with systemic lupus erythematosus and its correlation with Th1\/Th2 balance. Int J Clin Exp Pathol. 2021;14(5):646.","journal-title":"Int J Clin Exp Pathol"},{"key":"834_CR20","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.cca.2018.01.026","volume":"480","author":"H Li","year":"2018","unstructured":"Li H, Li K, Lai W, Li X, Wang H, et al. Comprehensive circular RNA profiles in plasma reveals that circular RNAs can be used as novel biomarkers for systemic lupus erythematosus. Clin Chim Acta. 2018;480:17\u201325. https:\/\/doi.org\/10.1016\/j.cca.2018.01.026.","journal-title":"Clin Chim Acta"},{"key":"834_CR21","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1146\/annurev-biochem-060308-103103","volume":"79","author":"MR Fabian","year":"2010","unstructured":"Fabian MR, Sonenberg N, Filipowicz W. Regulation of mRNA translation and stability by microRNAs. Annu Rev Biochem. 2010;79:351\u201379. https:\/\/doi.org\/10.1146\/annurev-biochem-060308-103103.","journal-title":"Annu Rev Biochem"},{"key":"834_CR22","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/s41576-023-00611-y","volume":"24","author":"R Shang","year":"2023","unstructured":"Shang R, Lee S, Senavirathne G, Lai EC. MicroRNAs in action: biogenesis, function and regulation. Nat Rev Genet. 2023;24:816\u201333. https:\/\/doi.org\/10.1038\/s41576-023-00611-y.","journal-title":"Nat Rev Genet"},{"key":"834_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-4939-7865-9_1","volume":"1","author":"S Ying","year":"2018","unstructured":"Ying S, Chang DC, Lin SL. The MicroRNA. MicroRNA Protoc. 2018;1:1\u201325. https:\/\/doi.org\/10.1007\/978-1-4939-7865-9_1.","journal-title":"MicroRNA Protoc"},{"key":"834_CR24","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1172\/JCI97426","volume":"128","author":"R Wu","year":"2018","unstructured":"Wu R, Du J, Lin Z, Zhang J, Li Y, Liu Y, et al. MicroRNA-210 overexpression promotes psoriasis-like inflammation by inducing Th1 and Th17 cell differentiation. J Clin Investig. 2018;128:2551\u201368. https:\/\/doi.org\/10.1172\/JCI97426.","journal-title":"J Clin Investig"},{"key":"834_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/cells11243952","volume":"11","author":"J Xu","year":"2022","unstructured":"Xu J, Zhang P, Li M, Zhou Y, Li Y. MiR-301a deficiency attenuates the macrophage migration and phagocytosis through YY1\/CXCR4 pathway. Cells. 2022;11:3952. https:\/\/doi.org\/10.3390\/cells11243952.","journal-title":"Cells"},{"key":"834_CR26","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1097\/SHK.0000000000000604","volume":"46","author":"K Essandoh","year":"2016","unstructured":"Essandoh K, Fan Y, Zhu X, Zhang Y, Wang Y, Lin S. MiRNA-mediated macrophage polarization and its potential role in the regulation of inflammatory response. Shock. 2016;46:122\u201331. https:\/\/doi.org\/10.1097\/SHK.0000000000000604.","journal-title":"Shock"},{"key":"834_CR27","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.nbd.2014.08.003","volume":"71","author":"HH Andersen","year":"2014","unstructured":"Andersen HH, Duroux M, Gazerani P. MicroRNAs as modulators and biomarkers of inflammatory and neuropathic pain conditions. Neurobiol Dis. 2014;71:159\u201368. https:\/\/doi.org\/10.1016\/j.nbd.2014.08.003.","journal-title":"Neurobiol Dis"},{"issue":"4","key":"834_CR28","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1146\/annurev-genet-120116-024611","volume":"19","author":"R Galupa","year":"2018","unstructured":"Galupa R, Heard E. X-chromosome inactivation: a crossroads between chromosome architecture and gene regulation. Nat Rev Genet. 2018;19(4):215\u201327. https:\/\/doi.org\/10.1146\/annurev-genet-120116-024611.","journal-title":"Nat Rev Genet"},{"issue":"12","key":"834_CR29","doi-asserted-by":"publisher","first-page":"e1117","DOI":"10.1002\/ctm2.1117","volume":"12","author":"L Liu","year":"2022","unstructured":"Liu L, Hu L, Long H, Zheng M, Hu Z, He Y, et al. LncRNA IL21-AS1 interacts with hnRNPU protein to promote IL21 overexpression and aberrant differentiation of Tfh cells in systemic lupus erythematosus. Clin Transl Med. 2022;12(12):e1117. https:\/\/doi.org\/10.1002\/ctm2.1117.","journal-title":"Clin Transl Med"},{"issue":"3","key":"834_CR30","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.cell.2018.01.011","volume":"172","author":"F Kopp","year":"2018","unstructured":"Kopp F, Mendell JT. Functional classification and experimental dissection of long noncoding rnas. Cell. 2018;172(3):393\u2013407. https:\/\/doi.org\/10.1016\/j.cell.2018.01.011.","journal-title":"Cell"},{"issue":"3","key":"834_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21031027","volume":"21","author":"M Kazimierczyk","year":"2020","unstructured":"Kazimierczyk M, Kasprowicz MK, Kasprzyk ME, Wrzesinski J. Human long noncoding rna interactome: detection, characterization and function. Int J Mol Sci. 2020;21(3):1027. https:\/\/doi.org\/10.3390\/ijms21031027.","journal-title":"Int J Mol Sci"},{"key":"834_CR32","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/82_2015_489","volume-title":"Long non-coding RNAs in human disease","author":"S Valadkhan","year":"2015","unstructured":"Valadkhan S, Valencia-Hip\u00f3lito A. lncRNAs in stress response. In: Mallick B, editor. Long non-coding RNAs in human disease. Singapore: Springer; 2015. p. 203\u201336. https:\/\/doi.org\/10.1007\/82_2015_489."},{"issue":"6","key":"834_CR33","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.molcel.2013.08.017","volume":"51","author":"Y Zhang","year":"2013","unstructured":"Zhang Y, Zhang XO, Chen T, Xiang JF, Yin QF, Xing YH, et al. Circular intronic long noncoding rnas. Mol Cell. 2013;51(6):792\u2013806. https:\/\/doi.org\/10.1016\/j.molcel.2013.08.017.","journal-title":"Mol Cell"},{"issue":"1","key":"834_CR34","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1146\/annurev-biochem-062917-012708","volume":"21","author":"JL Rinn","year":"2020","unstructured":"Rinn JL, Chang HY. Long noncoding rnas: molecular modalities to organismal functions. Nat Rev Mol Cell Biol. 2020;21(1):26\u201339. https:\/\/doi.org\/10.1146\/annurev-biochem-062917-012708.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"834_CR35","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.molcel.2014.08.019","volume":"56","author":"R Ashwal-Fluss","year":"2014","unstructured":"Ashwal-Fluss R, Meyer M, Pamudurti NR, Ivanov A, Bartok O, Hanan M, et al. CircRNA biogenesis competes with pre-mRNA splicing. Mol Cell. 2014;56(1):55\u201366. https:\/\/doi.org\/10.1016\/j.molcel.2014.08.019.","journal-title":"Mol Cell"},{"issue":"4","key":"834_CR36","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s10495-018-1453-z","volume":"23","author":"T Huang","year":"2018","unstructured":"Huang T, Wang M, Huang B, Chang A, Liu F, Zhang Y, et al. Long noncoding rnas in the mTOR signaling network: biomarkers and therapeutic targets. Apoptosis. 2018;23(4):255\u201364. https:\/\/doi.org\/10.1007\/s10495-018-1453-z.","journal-title":"Apoptosis"},{"key":"834_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.602731","volume":"8","author":"Q Zhai","year":"2020","unstructured":"Zhai Q, Zhao Y, Wang L, Dai Y, Zhao P, Xiang X, et al. CircRNA hsa_circ_0008500 acts as a miR-1301-3p sponge to promote osteoblast mineralization by upregulating PADI4. Front Cell Dev Biol. 2020;8:602731. https:\/\/doi.org\/10.3389\/fcell.2020.602731.","journal-title":"Front Cell Dev Biol."},{"key":"834_CR38","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.jbiotec.2016.09.011","volume":"238","author":"FR Kulcheski","year":"2016","unstructured":"Kulcheski FR, Christoff AP, Margis R. Circular rnas are miRNA sponges and can be used as a new class of biomarker. J Biotechnol. 2016;238:42\u201351. https:\/\/doi.org\/10.1016\/j.jbiotec.2016.09.011.","journal-title":"J Biotechnol"},{"issue":"18","key":"834_CR39","doi-asserted-by":"publisher","first-page":"5609","DOI":"10.1158\/0008-5472.CAN-13-1568","volume":"73","author":"TB Hansen","year":"2013","unstructured":"Hansen TB, Kjems J, Damgaard CK. Circular rna and miR-7 in cancer. Cancer Res. 2013;73(18):5609\u201312. https:\/\/doi.org\/10.1158\/0008-5472.CAN-13-1568.","journal-title":"Cancer Res"},{"issue":"8","key":"834_CR40","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.7150\/thno.42174","volume":"10","author":"A Huang","year":"2020","unstructured":"Huang A, Zheng H, Wu Z, Chen M, Huang Y. Circular RNA\u2013protein interactions: functions, mechanisms, and identification. Theranostics. 2020;10(8):3503\u201317. https:\/\/doi.org\/10.7150\/thno.42174.","journal-title":"Theranostics"},{"key":"834_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12429","volume":"7","author":"LM Holdt","year":"2016","unstructured":"Holdt LM, Stahringer A, Sass K, Pichler G, Kulak NA, Wilfert W, et al. Circular non-coding RNA ANRIL modulates ribosomal RNA maturation and atherosclerosis in humans. Nat Commun. 2016;7:12429. https:\/\/doi.org\/10.1038\/ncomms12429.","journal-title":"Nat Commun"},{"issue":"1","key":"834_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-023-01300-9","volume":"9","author":"R Zhao","year":"2023","unstructured":"Zhao R, Chen P, Qu C, Liang J, Cheng Y, Sun Z, et al. Circular RNA circTRPS1-2 inhibits the proliferation and migration of esophageal squamous cell carcinoma by reducing the production of ribosomes. Cell Death Discov. 2023;9(1):5. https:\/\/doi.org\/10.1038\/s41420-023-01300-9.","journal-title":"Cell Death Discov"},{"issue":"1","key":"834_CR43","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13059-018-1594-y","volume":"19","author":"N Chen","year":"2018","unstructured":"Chen N, Zhao G, Yan X, Lv Z, Yin H, Zhang S, et al. A novel FLI1 exonic circular RNA promotes metastasis in breast cancer by coordinately regulating TET1 and DNMT1. Genome Biol. 2018;19(1):33. https:\/\/doi.org\/10.1186\/s13059-018-1594-y.","journal-title":"Genome Biol"},{"issue":"2","key":"834_CR44","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.molcel.2017.05.022","volume":"67","author":"YG Chen","year":"2017","unstructured":"Chen YG, Kim MV, Chen X, Batista PJ, Aoyama S, Wilusz JE, et al. Sensing self and foreign circular RNAs by intron identity. Mol Cell. 2017;67(2):228-38.e5. https:\/\/doi.org\/10.1016\/j.molcel.2017.05.022.","journal-title":"Mol Cell"},{"issue":"2","key":"834_CR45","doi-asserted-by":"publisher","first-page":"214","DOI":"10.7150\/ijbs.22531","volume":"67","author":"X Li","year":"2017","unstructured":"Li X, Liu CX, Xue W, Zhang Y, Jiang S, Yin QF, et al. Coordinated circRNA biogenesis and function with NF90\/NF110 in viral infection. Mol Cell. 2017;67(2):214-27.e7. https:\/\/doi.org\/10.7150\/ijbs.22531.","journal-title":"Mol Cell"},{"issue":"8","key":"834_CR46","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1038\/cr.2015.82","volume":"25","author":"Y Li","year":"2015","unstructured":"Li Y, Zheng Q, Bao C, Li S, Guo W, Zhao J, et al. Circular RNA is enriched and stable in exosomes: a promising biomarker for cancer diagnosis. Cell Res. 2015;25(8):981\u20134. https:\/\/doi.org\/10.1038\/cr.2015.82.","journal-title":"Cell Res"},{"key":"834_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-019-1041-z","volume":"18","author":"Y Wang","year":"2019","unstructured":"Wang Y, Liu J, Ma J, Sun T, Zhou Q, Wang W, et al. Exosomal circRNAs: biogenesis, effect and application in human diseases. Mol Cancer. 2019;18:1\u201310. https:\/\/doi.org\/10.1186\/s12943-019-1041-z.","journal-title":"Mol Cancer"},{"issue":"1","key":"834_CR48","doi-asserted-by":"publisher","DOI":"10.1080\/20013078.2018.1424473","volume":"7","author":"C Preu\u00dfer","year":"2018","unstructured":"Preu\u00dfer C, Hung LH, Schneider T, Schreiner S, Hardt M, Moebus A, et al. Selective release of circRNAs in platelet-derived extracellular vesicles. J Extracell Vesicles. 2018;7(1):1424473. https:\/\/doi.org\/10.1080\/20013078.2018.1424473.","journal-title":"J Extracell Vesicles"},{"key":"834_CR49","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.30330","author":"MA Ameer","year":"2022","unstructured":"Ameer MA, Chaudhry H, Mushtaq J, Khan OS, Babar M, et al. An overview of systemic lupus erythematosus (SLE) pathogenesis, classification, and management. Cureus. 2022. https:\/\/doi.org\/10.7759\/cureus.30330.","journal-title":"Cureus."},{"key":"834_CR50","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.cellimm.2017.06.004","volume":"319","author":"LJ Li","year":"2017","unstructured":"Li LJ, Zhao W, Tao SS, Li J, Xu SZ, Wang JB, et al. Comprehensive long non-coding RNA expression profiling reveals their potential roles in systemic lupus erythematosus. Cell Immunol. 2017;319:17\u201327. https:\/\/doi.org\/10.1016\/j.cellimm.2017.06.004.","journal-title":"Cell Immunol"},{"key":"834_CR51","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.807895","volume":"12","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, Huang Q, Yu L, Zhu D, Li Y, Xue Z, et al. The role of miRNA in tumor immune escape and miRNA-based therapeutic strategies. Front Immunol. 2022;12:807895. https:\/\/doi.org\/10.3389\/fimmu.2021.807895.","journal-title":"Front Immunol"},{"key":"834_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12026-021-09247-8","volume":"70","author":"Y Sharma","year":"2022","unstructured":"Sharma Y, Sharma A, Sharma P, Gupta S, Kujur P, Gupta A, et al. Host miRNA and immune cell interactions: relevance in nano-therapeutics for human health. Immunol Res. 2022;70:1\u201318. https:\/\/doi.org\/10.1007\/s12026-021-09247-8.","journal-title":"Immunol Res"},{"key":"834_CR53","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.607044","volume":"12","author":"AN Renrick","year":"2021","unstructured":"Renrick AN, Kunkle H, D\u2019Amico S, Araya-Anwandter M, Ewen-Campen S. Bortezomib sustains T cell function by inducing miR-155-mediated downregulation of SOCS1 and SHIP1. Front Immunol. 2021;12:607044. https:\/\/doi.org\/10.3389\/fimmu.2021.607044.","journal-title":"Front Immunol"},{"key":"834_CR54","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1186\/s12951-022-01522-6","volume":"20","author":"T Hua","year":"2022","unstructured":"Hua T, Li Q, Hu X, Guo S, Wang R, Huang H, et al. Huc-MSCs-derived exosomes attenuate inflammatory pain by regulating microglia pyroptosis and autophagy via the miR-146a-5p\/TRAF6 axis. J Nanobiotechnol. 2022;20:324. https:\/\/doi.org\/10.1186\/s12951-022-01522-6.","journal-title":"J Nanobiotechnol"},{"issue":"1","key":"834_CR55","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-025-13464-x","volume":"25","author":"L He","year":"2025","unstructured":"He L, Li L, Zhao L, Guan X, Guo Y, Han Q, et al. CircCCT2\/miR-146a-5p\/IRAK1 axis promotes the development of head and neck squamous cell carcinoma. BMC Cancer. 2025;25(1):84.","journal-title":"BMC Cancer"},{"issue":"6","key":"834_CR56","doi-asserted-by":"publisher","DOI":"10.1111\/sji.13167","volume":"95","author":"X Chen","year":"2022","unstructured":"Chen X, Cheng Q, Wu H, Du Y. Long non\u2010coding RNAs in systemic lupus erythematosus: new insights into disease pathogenesis and diagnosis. Scand J Immunol. 2022;95(6):e13167. https:\/\/doi.org\/10.1111\/sji.13167.","journal-title":"Scand J Immunol"},{"issue":"44","key":"834_CR57","doi-asserted-by":"publisher","first-page":"77400","DOI":"10.18632\/oncotarget.20490","volume":"8","author":"H Yang","year":"2017","unstructured":"Yang H, Liang N, Wang M, Fei Y, Sun J, Li Z, et al. Long noncoding RNA MALAT-1 is a novel inflammatory regulator in human systemic lupus erythematosus. Oncotarget. 2017;8(44):77400. https:\/\/doi.org\/10.18632\/oncotarget.20490.","journal-title":"Oncotarget"},{"issue":"14","key":"834_CR58","doi-asserted-by":"publisher","first-page":"23650","DOI":"10.18632\/oncotarget.15569","volume":"8","author":"GC Wu","year":"2017","unstructured":"Wu GC, Li J, Leng RX, Li XP, Li XM, Wang DG, et al. Identification of long non-coding RNAs GAS5, linc0597 and lnc-DC in plasma as novel biomarkers for systemic lupus erythematosus. Oncotarget. 2017;8(14):23650. https:\/\/doi.org\/10.18632\/oncotarget.15569.","journal-title":"Oncotarget"},{"key":"834_CR59","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.molimm.2018.07.029","volume":"101","author":"Q Ouyang","year":"2018","unstructured":"Ouyang Q, Huang Q, Jiang Z, Zhao J, Shi GP, Yang M. Using plasma circRNA_002453 as a novel biomarker in the diagnosis of lupus nephritis. Mol Immunol. 2018;101:531\u20138. https:\/\/doi.org\/10.1016\/j.molimm.2018.07.029.","journal-title":"Mol Immunol"},{"key":"834_CR60","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1007\/s10067-018-4392-8","volume":"38","author":"S Li","year":"2019","unstructured":"Li S, Zhang J, Tan X, Deng J, Li Y, Piao Y, et al. Microarray expression profile of circular RNAs and mRNAs in children with systemic lupus erythematosus. Clin Rheumatol. 2019;38:1339\u201350. https:\/\/doi.org\/10.1007\/s10067-018-4392-8.","journal-title":"Clin Rheumatol"},{"key":"834_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13075-018-1618-8","volume":"20","author":"X Wang","year":"2018","unstructured":"Wang X, Zhang C, Wu Z, Chen Y, Shi W. CircIBTK inhibits DNA demethylation and activation of AKT signaling pathway via mir-29b in peripheral blood mononuclear cells in systemic lupus erythematosus. Arthritis Res Ther. 2018;20:1\u201310. https:\/\/doi.org\/10.1186\/s13075-018-1618-8.","journal-title":"Arthritis Res Ther"},{"key":"834_CR62","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.omtn.2017.12.006","volume":"10","author":"J Luan","year":"2018","unstructured":"Luan J, Jiao C, Kong W, Fu J, Qu W, Ying C, et al. circHLA-C plays an important role in lupus nephritis by sponging miR-150. Mol Ther Nucleic Acids. 2018;10:245\u201353. https:\/\/doi.org\/10.1016\/j.omtn.2017.12.006.","journal-title":"Mol Ther Nucleic Acids."},{"issue":"6","key":"834_CR63","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1002128","volume":"7","author":"X Luo","year":"2011","unstructured":"Luo X, Yang W, Ye DQ, Cui H, Zhang Y, Hirankarn N, et al. A functional variant in microrna-146a promoter modulates its expression and confers disease risk for systemic lupus erythematosus. PLoS Genet. 2011;7(6):e1002128. https:\/\/doi.org\/10.1371\/journal.pgen.1002128.","journal-title":"PLoS Genet"},{"issue":"1","key":"834_CR64","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13148-015-0063-7","volume":"7","author":"S Luo","year":"2015","unstructured":"Luo S, Lu J, Li W, Zeng J, Zhang H, Zhang S, et al. The role of microRNA-1246 in the regulation of B cell activation and the pathogenesis of systemic lupus erythematosus. Clin Epigenet. 2015;7(1):24. https:\/\/doi.org\/10.1186\/s13148-015-0063-7.","journal-title":"Clin Epigenet"},{"issue":"1","key":"834_CR65","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.jdermsci.2012.10.011","volume":"69","author":"H Qin","year":"2013","unstructured":"Qin H, Luo X, Ma W, Zhang Y, Sun W, Huang Z, et al. MicroRNA-29b contributes to DNA hypomethylation of CD4+ T cells in systemic lupus erythematosus by indirectly targeting DNA methyltransferase 1. J Dermatol Sci. 2013;69(1):61\u20137. https:\/\/doi.org\/10.1016\/j.jdermsci.2012.10.011.","journal-title":"J Dermatol Sci"},{"key":"834_CR66","doi-asserted-by":"publisher","DOI":"10.12659\/msm.906507","volume":"24","author":"C Zhang","year":"2018","unstructured":"Zhang C, Huang J, Chen Y, Shi W. Low expression and clinical value of hsa_circ_0049224 and has_circ_0049220 in systemic lupus erythematous patients. Med Sci Monit. 2018;24:1930. https:\/\/doi.org\/10.12659\/msm.906507.","journal-title":"Med Sci Monit"},{"issue":"1","key":"834_CR67","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/imm.12940","volume":"155","author":"LJ Li","year":"2018","unstructured":"Li LJ, Zhu ZW, Zhao W, Tao SS, Li BZ, Xu SZ, et al. Circular RNA expression profile and potential function of hsa_circ_0045272 in systemic lupus erythematosus. Immunology. 2018;155(1):137\u201349. https:\/\/doi.org\/10.1111\/imm.12940.","journal-title":"Immunology"},{"issue":"23","key":"834_CR68","doi-asserted-by":"publisher","first-page":"15676","DOI":"10.1074\/jbc.M809787200","volume":"284","author":"Z Li","year":"2009","unstructured":"Li Z, Hassan MQ, Jafferji M, Aqeilan RI, Garzon R, Croce CM, et al. Biological functions of miR-29b contribute to the positive regulation of osteoblast differentiation. J Biol Chem. 2009;284(23):15676\u201384. https:\/\/doi.org\/10.1074\/jbc.M809787200.","journal-title":"J Biol Chem"},{"issue":"2","key":"834_CR69","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.0040007","volume":"4","author":"TS Lisse","year":"2008","unstructured":"Lisse TS, Thiele F, Fuchs H, Hans W, Przemeck GKH, Abe K, et al. H. ER stress-mediated apoptosis in a new mouse model of osteogenesis imperfecta. PLoS Genet. 2008;4(2):e7. https:\/\/doi.org\/10.1371\/journal.pgen.0040007.","journal-title":"PLoS Genet"},{"issue":"37","key":"834_CR70","doi-asserted-by":"publisher","first-page":"13906","DOI":"10.1073\/pnas.0804438105","volume":"105","author":"Z Li","year":"2008","unstructured":"Li Z, Hassan MQ, Volinia S, van Wijnen AJ, Stein JL, Croce CM, et al. A microrna signature for a BMP2-induced osteoblast lineage commitment program. Proc Natl Acad Sci USA. 2008;105(37):13906\u201311. https:\/\/doi.org\/10.1073\/pnas.0804438105.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"834_CR71","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0003726","volume":"3","author":"G Tzur","year":"2008","unstructured":"Tzur G, Levy A, Meiri E, Barad O, Spector Y, Bentwich Z, et al. Microrna expression patterns and function in endodermal differentiation of human embryonic stem cells. PLoS ONE. 2008;3(11):e3726. https:\/\/doi.org\/10.1371\/journal.pone.0003726.","journal-title":"PLoS ONE"},{"issue":"2","key":"834_CR72","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1002\/stem.288","volume":"28","author":"J Huang","year":"2010","unstructured":"Huang J, Zhao L, Xing L, Chen D. Microrna-204 regulates Runx2 protein expression and mesenchymal progenitor cell differentiation. Stem Cells. 2010;28(2):357\u201364. https:\/\/doi.org\/10.1002\/stem.288.","journal-title":"Stem Cells"},{"issue":"3","key":"834_CR73","doi-asserted-by":"publisher","first-page":"218","DOI":"10.14348\/molcells.2018.0162","volume":"42","author":"Z Zhang","year":"2019","unstructured":"Zhang Z, Zou G, Chen X, et al. Knockdown of lncRNA PVT1 inhibits vascular smooth muscle cell apoptosis and extracellular matrix disruption in a murine abdominal aortic aneurysm model. Mol Cells. 2019;42(3):218\u201327. https:\/\/doi.org\/10.14348\/molcells.2018.0162.","journal-title":"Mol Cells"},{"issue":"2","key":"834_CR74","doi-asserted-by":"publisher","first-page":"12583","DOI":"10.1080\/21655979.2021.2010384","volume":"12","author":"Y Huang","year":"2021","unstructured":"Huang Y, Ren L, Li J, Zou H. Long non-coding RNA PVT1\/microRNA miR-3127-5p\/NCK-associated protein 1-like axis participates in the pathogenesis of abdominal aortic aneurysm by regulating vascular smooth muscle cells. Bioengineered. 2021;12(2):12583\u201396. https:\/\/doi.org\/10.1080\/21655979.2021.2010384.","journal-title":"Bioengineered"},{"issue":"14","key":"834_CR75","doi-asserted-by":"publisher","first-page":"6029","DOI":"10.1158\/0008-5472.CAN-05-0137","volume":"65","author":"JA Chan","year":"2005","unstructured":"Chan JA, Krichevsky AM, Kosik KS. Microrna-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res. 2005;65(14):6029\u201333. https:\/\/doi.org\/10.1158\/0008-5472.CAN-05-0137.","journal-title":"Cancer Res"},{"key":"834_CR76","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1161\/CIRCRESAHA.106.141986","volume":"100","author":"R Ji","year":"2007","unstructured":"Ji R, Cheng Y, Yue J, Yang J, Liu X, Chen H, et al. Microrna expression signature and antisense-mediated depletion reveal an essential role of microRNA in vascular neointimal lesion formation. Circ Res. 2007;100:1579\u201388. https:\/\/doi.org\/10.1161\/CIRCRESAHA.106.141986.","journal-title":"Circ Res"},{"key":"834_CR77","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1093\/cvr\/cvp015","volume":"82","author":"S Roy","year":"2009","unstructured":"Roy S, Khanna S, Hussain SR, Biswas S, Azad A, Rink C, et al. Microrna expression in response to murine myocardial infarction: mir-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologue. Cardiovasc Res. 2009;82:21\u20139. https:\/\/doi.org\/10.1093\/cvr\/cvp015.","journal-title":"Cardiovasc Res"},{"key":"834_CR78","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1038\/nature07511","volume":"456","author":"T Thum","year":"2008","unstructured":"Thum T, Gross C, Fiedler J, Fischer T, Kissler S, Bussen M, et al. Microrna-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature. 2008;456:980\u20134. https:\/\/doi.org\/10.1038\/nature07511.","journal-title":"Nature"},{"key":"834_CR79","doi-asserted-by":"publisher","first-page":"C1481","DOI":"10.1152\/ajpcell.00413.2009","volume":"298","author":"X Liu","year":"2010","unstructured":"Liu X, Cheng Y, Yang J, Krall TJ, Huo Y, Zhang C. An essential role of PDCD4 in vascular smooth muscle cell apoptosis and proliferation: implications for vascular disease. Am J Physiol Cell Physiol. 2010;298:C1481\u20138. https:\/\/doi.org\/10.1152\/ajpcell.00413.2009.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"2","key":"834_CR80","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/ng1725","volume":"38","author":"JF Chen","year":"2006","unstructured":"Chen JF, Mandel EM, Thomson JM, Wu Q, Callis TE, Hammond SM, et al. The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat Genet. 2006;38(2):228\u201333. https:\/\/doi.org\/10.1038\/ng1725.","journal-title":"Nat Genet"},{"issue":"122","key":"834_CR81","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3003441","volume":"4","author":"L Maegdefessel","year":"2012","unstructured":"Maegdefessel L, Azuma J, Toh R, Deng A, Merk DR, Raiesdana A, et al. MicroRNA-21 blocks abdominal aortic aneurysm development and nicotine-augmented expansion. Sci Transl Med. 2012;4(122):122ra22. https:\/\/doi.org\/10.1126\/scitranslmed.3003441.","journal-title":"Sci Transl Med"},{"issue":"1","key":"834_CR82","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1042\/BSR20202298","volume":"41","author":"M Ren","year":"2021","unstructured":"Ren M, Wu J, Zhang Y, et al. LncRNA H19 regulates smooth muscle cell functions and participates in the development of aortic dissection through sponging miR-193b-3p. Biosci Rep. 2021;41(1):8. https:\/\/doi.org\/10.1042\/BSR20202298.","journal-title":"Biosci Rep"},{"key":"834_CR83","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.yjmcc.2019.04.004","volume":"131","author":"Y Sun","year":"2019","unstructured":"Sun Y, Zhong L, He X, Wang S, Lai Y, Wu W, et al. LncRNA H19 promotes vascular inflammation and abdominal aortic aneurysm formation by functioning as a competing endogenous RNA. J Mol Cell Cardiol. 2019;131:66\u201381. https:\/\/doi.org\/10.1016\/j.yjmcc.2019.04.004.","journal-title":"J Mol Cell Cardiol"},{"issue":"5","key":"834_CR84","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1101\/gad.234419.113","volume":"28","author":"B Dey","year":"2014","unstructured":"Dey B, Pfeifer K, Dutta A. The H19 long noncoding RNA gives rise to microRNAs miR-675-3p and miR-675-5p to promote skeletal muscle differentiation and regeneration. Genes Dev. 2014;28(5):491\u2013501. https:\/\/doi.org\/10.1101\/gad.234419.113.","journal-title":"Genes Dev"},{"issue":"1","key":"834_CR85","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2021.103604","volume":"25","author":"L Ouyang","year":"2021","unstructured":"Ouyang L, Sun Y, Lv D, Peng X, Liu X, Ci L, et al. miR-29cb2 promotes angiogenesis and osteogenesis by inhibiting HIF-3\u03b1 in bone. iScience. 2021;25(1):103604. https:\/\/doi.org\/10.1016\/j.isci.2021.103604.","journal-title":"iScience"},{"issue":"23","key":"834_CR86","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1161\/CIRCULATIONAHA.121.055949","volume":"144","author":"K Dong","year":"2021","unstructured":"Dong K, Shen J, He X, Hu G, Wang L, Osman I, et al. CARMN is an evolutionarily conserved smooth muscle cell-specific LncRNA that maintains contractile phenotype by binding myocardin. Circulation. 2021;144(23):1856\u201375. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.121.055949.","journal-title":"Circulation"},{"issue":"6","key":"834_CR87","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.jacbts.2016.06.008","volume":"1","author":"I Plaisance","year":"2016","unstructured":"Plaisance I, Perruchoud S, Fernandez-Tenorio M, Gonzales C, Ounzain S, Ruchat P, et al. Cardiomyocyte lineage specification in adult human cardiac precursor cells via modulation of enhancer-associated long noncoding RNA expression. JACC Basic Transl Sci. 2016;1(6):472\u201393. https:\/\/doi.org\/10.1016\/j.jacbts.2016.06.008.","journal-title":"JACC Basic Transl Sci"},{"issue":"1","key":"834_CR88","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-024-05193-4","volume":"81","author":"S Liu","year":"2024","unstructured":"Liu S, Zhou H, Han D, Song H, Li Y, He S, et al. LncRNA CARMN inhibits abdominal aortic aneurysm formation and vascular smooth muscle cell phenotypic transformation by interacting with SRF. Cell Mol Life Sci. 2024;81(1):175. https:\/\/doi.org\/10.1007\/s00018-024-05193-4.","journal-title":"Cell Mol Life Sci"},{"key":"834_CR89","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1161\/ATVBAHA.113.303134","volume":"34","author":"CW Kim","year":"2014","unstructured":"Kim CW, Kumar S, Son DJ, Jang IH, Griendling KK, Jo H. Prevention of abdominal aortic aneurysm by anti-microRNA-712 or anti-microRNA-205 in angiotensin II-infused mice. Arterioscler Thromb Vasc Biol. 2014;34:1412\u201321. https:\/\/doi.org\/10.1161\/ATVBAHA.113.303134.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"834_CR90","doi-asserted-by":"publisher","first-page":"124","DOI":"10.5114\/kitp.2019.88601","volume":"16","author":"A Borek","year":"2019","unstructured":"Borek A, Drzyma\u0142a F, Botor M, Augu\u015bciak-Duma AM, Siero\u0144 AL. Roles of microRNAs in abdominal aortic aneurysm pathogenesis and the possibility of their use as biomarkers. Pol J Cardio-Thorac Surg. 2019;16(3):124\u20137. https:\/\/doi.org\/10.5114\/kitp.2019.88601.","journal-title":"Pol J Cardio-Thorac Surg"},{"key":"834_CR91","doi-asserted-by":"publisher","first-page":"373","DOI":"10.3892\/ijmm.2017.2852","volume":"39","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Zhang Y, Li X, Zhang M, Lv K. Microarray analysis of circular RNA expression patterns in polarized macrophages. Int J Mol Med. 2017;39:373\u20139. https:\/\/doi.org\/10.3892\/ijmm.2017.2852.","journal-title":"Int J Mol Med"},{"issue":"2","key":"834_CR92","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/j.ymthe.2021.09.017","volume":"30","author":"H Song","year":"2022","unstructured":"Song H, Yang Y, Sun Y, Wei G, Zheng H, Chen Y, et al. Circular RNA Cdyl promotes abdominal aortic aneurysm formation by inducing M1 macrophage polarization and M1-type inflammation. Mol Ther. 2022;30(2):915\u201331. https:\/\/doi.org\/10.1016\/j.ymthe.2021.09.017.","journal-title":"Mol Ther"},{"issue":"1","key":"834_CR93","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1006\/dbio.1998.9107","volume":"205","author":"S Kherif","year":"1999","unstructured":"Kherif S, Lafuma C, Dehaupas M, Lachkar S, Fournier JG, Verdiere-Sahuque M, et al. Expression of matrix metalloproteinases 2 and 9 in regenerating skeletal muscle: a study in experimentally injured and mdx muscles. Dev Biol. 1999;205(1):158\u201370. https:\/\/doi.org\/10.1006\/dbio.1998.9107.","journal-title":"Dev Biol"},{"key":"834_CR94","doi-asserted-by":"publisher","first-page":"e000745","DOI":"10.1161\/JAHA.112.000745","volume":"1","author":"K Kin","year":"2012","unstructured":"Kin K, Miyagawa S, Fukushima S, Shirakawa Y, Torikai K, Shimamura K, et al. Tissue- and plasma-specific microRNA signatures for atherosclerotic abdominal aortic aneurysm. J Am Heart Assoc. 2012;1:e000745. https:\/\/doi.org\/10.1161\/JAHA.112.000745.","journal-title":"J Am Heart Assoc"},{"key":"834_CR95","doi-asserted-by":"publisher","first-page":"6542","DOI":"10.4049\/jimmunol.1202496","volume":"190","author":"S Banerjee","year":"2013","unstructured":"Banerjee S, Xie N, Cui H, Tan Z, Yang S, Icyuz M, et al. MicroRNA let-7c regulates macrophage polarization. J Immunol. 2013;190:6542\u20139. https:\/\/doi.org\/10.4049\/jimmunol.1202496.","journal-title":"J Immunol"},{"key":"834_CR96","first-page":"67","volume-title":"Inflammation and inflammatory diseases, markers, and mediators: role of CRP in some inflammatory diseases. Biology of C reactive protein in health and disease","author":"W Ansar","year":"2016","unstructured":"Ansar W, Ghosh S. Inflammation and inflammatory diseases, markers, and mediators: role of CRP in some inflammatory diseases. Biology of C reactive protein in health and disease. New Delhi: Springer India; 2016. p. 67\u2013107."},{"issue":"2","key":"834_CR97","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1634\/theoncologist.12-2-142","volume":"12","author":"CR James","year":"2007","unstructured":"James CR, Quinn JE, Mullan PB, Johnston PG, Harkin DP. BRCA1, a potential predictive biomarker in the treatment of breast cancer. Oncologist. 2007;12(2):142\u201350. https:\/\/doi.org\/10.1634\/theoncologist.12-2-142.","journal-title":"Oncologist"},{"issue":"3","key":"834_CR98","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1177\/1535370217750088","volume":"243","author":"RM Califf","year":"2018","unstructured":"Califf RM. Biomarker definitions and their applications. Exp Biol Med (Maywood). 2018;243(3):213\u201321. https:\/\/doi.org\/10.1177\/1535370217750088.","journal-title":"Exp Biol Med (Maywood)"},{"issue":"4","key":"834_CR99","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1097\/ALN.0b013e3181d47604","volume":"112","author":"P Ray","year":"2010","unstructured":"Ray P, Le Manach Y, Riou B, Houle TT, Warner DS. Statistical evaluation of a biomarker. Anesthesiology. 2010;112(4):1023\u201340. https:\/\/doi.org\/10.1097\/ALN.0b013e3181d47604.","journal-title":"Anesthesiology"},{"issue":"1","key":"834_CR100","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00441-023-03816-z","volume":"394","author":"S Ng","year":"2023","unstructured":"Ng S, Masarone S, Watson D, Barnes MR. The benefits and pitfalls of machine learning for biomarker discovery. Cell Tissue Res. 2023;394(1):17\u201331. https:\/\/doi.org\/10.1007\/s00441-023-03816-z.","journal-title":"Cell Tissue Res"},{"issue":"2","key":"834_CR101","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e13345","volume":"9","author":"W Song","year":"2023","unstructured":"Song W, Li C, Qiu J, Dong J, Liu D, Dai Y. Differential expression of exosomal miRNAs and proteins in the plasma of systemic lupus erythematous patients. Heliyon. 2023;9(2):e13345. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e13345.","journal-title":"Heliyon"},{"issue":"5","key":"834_CR102","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1002\/art.37890","volume":"65","author":"AL Carlsen","year":"2013","unstructured":"Carlsen AL, Schetter AJ, Nielsen CT, Lood C, Knudsen S, Voss A, et al. Circulating microRNA expression profiles associated with systemic lupus erythematosus. Arthritis Rheum. 2013;65(5):1324\u201334. https:\/\/doi.org\/10.1002\/art.37890.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"834_CR103","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-016-1081-3","volume":"18","author":"VL Souliotis","year":"2016","unstructured":"Souliotis VL, Vougas K, Gorgoulis VG, Sfikakis PP. Defective DNA repair and chromatin organization in patients with quiescent systemic lupus erythematosus. Arthritis Res Ther. 2016;18(1):182. https:\/\/doi.org\/10.1186\/s13075-016-1081-3.","journal-title":"Arthritis Res Ther"},{"issue":"9","key":"834_CR104","doi-asserted-by":"publisher","first-page":"2953","DOI":"10.1002\/art.34505","volume":"64","author":"S Ding","year":"2012","unstructured":"Ding S, Liang Y, Zhao M, Liang G, Long H, Zhao S, et al. Decreased microRNA-142-3p\/5p expression causes CD4+ T cell activation and B cell hyperstimulation in systemic lupus erythematosus. Arthritis Rheum. 2012;64(9):2953\u201363. https:\/\/doi.org\/10.1002\/art.34505.","journal-title":"Arthritis Rheum"},{"issue":"5","key":"834_CR105","doi-asserted-by":"publisher","DOI":"10.1002\/jgm.3326","volume":"23","author":"RS Abdul-Maksoud","year":"2021","unstructured":"Abdul-Maksoud RS, Rashad NM, Elsayed WSH, Ali MA, Kamal NM, Zidan HE. Circulating miR-181a and miR-223 expression with the potential value of biomarkers for the diagnosis of systemic lupus erythematosus and predicting lupus nephritis. J Gene Med. 2021;23(5):e3326. https:\/\/doi.org\/10.1002\/jgm.3326.","journal-title":"J Gene Med"},{"issue":"4","key":"834_CR106","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21041372","volume":"21","author":"E Garcia-Vives","year":"2020","unstructured":"Garcia-Vives E, Sol\u00e9 C, Molin\u00e9 T, Vidal M, Agraz I, Ordi-Ros J, et al. The urinary exosomal miRNA expression profile is predictive of clinical response in lupus nephritis. Int J Mol Sci. 2020;21(4):1372. https:\/\/doi.org\/10.3390\/ijms21041372.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"834_CR107","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1681\/ASN.2012080849","volume":"24","author":"H Zhou","year":"2013","unstructured":"Zhou H, Hasni SA, Perez P, Tandon M, Jang AI, Zheng C, et al. miR-150 promotes renal fibrosis in lupus nephritis by downregulating SOCS1. J Am Soc Nephrol. 2013;24(7):1073\u201387. https:\/\/doi.org\/10.1681\/ASN.2012080849.","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"834_CR108","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1093\/ndt\/gfv128","volume":"30","author":"C Sol\u00e9","year":"2015","unstructured":"Sol\u00e9 C, Cort\u00e9s-Hern\u00e1ndez J, Felip ML, Vidal M, Ordi-Ros J. MiR-29c in urinary exosomes as predictor of early renal fibrosis in lupus nephritis. Nephrol Dial Transplant. 2015;30(9):1488\u201396. https:\/\/doi.org\/10.1093\/ndt\/gfv128.","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"834_CR109","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-020-00895-7","volume":"22","author":"SM Hong","year":"2020","unstructured":"Hong SM, Liu C, Yin Z, Wu L, Qu B, Shen N. Micrornas in systemic lupus erythematosus: a perspective on the path from biological discoveries to clinical practice. Curr Rheumatol Rep. 2020;22(1):9. https:\/\/doi.org\/10.1007\/s11926-020-00895-7.","journal-title":"Curr Rheumatol Rep"},{"issue":"8","key":"834_CR110","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13082339","volume":"13","author":"MH Omer","year":"2024","unstructured":"Omer MH, Shafqat A, Ahmad O, Nadri J, AlKattan K, Yaqinuddin A. Urinary biomarkers for lupus nephritis: a systems biology approach. J Clin Med. 2024;13(8):2339. https:\/\/doi.org\/10.3390\/jcm13082339.","journal-title":"J Clin Med"},{"key":"834_CR111","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1020891","volume":"13","author":"J Liang","year":"2022","unstructured":"Liang J, Xie F, Feng J, Huang C, Shen J, Han Z, et al. Progress in the application of body fluid and tissue level mRNAs\u2013non-coding RNAs for the early diagnosis and prognostic evaluation of systemic lupus erythematosus. Front Immunol. 2022;13:1020891. https:\/\/doi.org\/10.3389\/fimmu.2022.1020891.","journal-title":"Front Immunol"},{"key":"834_CR112","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.792884","volume":"12","author":"H Wu","year":"2021","unstructured":"Wu H, Chen S, Li A, Shen K, Wang S, Wang S, et al. LncRNA expression profiles in systemic lupus erythematosus and rheumatoid arthritis: emerging biomarkers and therapeutic targets. Front Immunol. 2021;12:792884. https:\/\/doi.org\/10.3389\/fimmu.2021.792884.","journal-title":"Front Immunol"},{"issue":"6","key":"834_CR113","doi-asserted-by":"publisher","DOI":"10.3390\/biom10060937","volume":"10","author":"M Taheri","year":"2020","unstructured":"Taheri M, Eghtedarian R, Dinger ME, Ghafouri-Fard S. Exploring the role of non-coding RNAs in the pathophysiology of systemic lupus erythematosus. Biomolecules. 2020;10(6):937. https:\/\/doi.org\/10.3390\/biom10060937.","journal-title":"Biomolecules"},{"issue":"1","key":"834_CR114","doi-asserted-by":"publisher","first-page":"345","DOI":"10.3892\/etm.2017.5429","volume":"15","author":"QF Suo","year":"2018","unstructured":"Suo QF, Sheng J, Qiang FY, Tang ZS, Yang YY. Association of long non-coding RNA GAS5 and miR-21 levels in CD4+ T cells with clinical features of systemic lupus erythematosus. Exp Ther Med. 2018;15(1):345\u201350. https:\/\/doi.org\/10.3892\/etm.2017.5429.","journal-title":"Exp Ther Med"},{"issue":"4","key":"834_CR115","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1177\/0961203319830493","volume":"28","author":"Q Miao","year":"2019","unstructured":"Miao Q, Zhong Z, Jiang Z, Lin Y, Ni B, et al. RNA-seq of circular RNAs identified circPTPN22 as a potential new activity indicator in systemic lupus erythematosus. Lupus. 2019;28(4):520\u20138. https:\/\/doi.org\/10.1177\/0961203319830493.","journal-title":"Lupus"},{"key":"834_CR116","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.cca.2018.01.026","volume":"480","author":"H Li","year":"2018","unstructured":"Li H, Li K, Lai W, Li X, Wang H, Yang J, et al. Comprehensive circular RNA profiles in plasma reveals that circular RNAs can be used as novel biomarkers for systemic lupus erythematosus. Clin Chim Acta. 2018;480:17\u201325. https:\/\/doi.org\/10.1016\/j.cca.2018.01.026.","journal-title":"Clin Chim Acta"},{"issue":"4","key":"834_CR117","doi-asserted-by":"publisher","first-page":"330","DOI":"10.2174\/1389450122666210806124425","volume":"23","author":"C Ma","year":"2022","unstructured":"Ma C, Luan J, Kopp JB, Zhou H. Emerging role of circular RNAs in kidney diseases in nephrology. Curr Drug Targets. 2022;23(4):330\u201343. https:\/\/doi.org\/10.2174\/1389450122666210806124425.","journal-title":"Curr Drug Targets"},{"issue":"7","key":"834_CR118","doi-asserted-by":"publisher","DOI":"10.3390\/biom10071044","volume":"10","author":"V Lodde","year":"2020","unstructured":"Lodde V, Murgia G, Simula ER, Steri M, Floris M, Idda ML. Long noncoding rnas and circular rnas in autoimmune diseases. Biomolecules. 2020;10(7):1044. https:\/\/doi.org\/10.3390\/biom10071044.","journal-title":"Biomolecules"},{"issue":"6","key":"834_CR119","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s00223-020-00802-3","volume":"108","author":"K Kerschan-Schindl","year":"2021","unstructured":"Kerschan-Schindl K, Hackl M, Boschitsch E, F\u00f6ger-Samwald U, N\u00e4gele O, Skalicky S, et al. Diagnostic performance of a panel of mirnas (OsteomiR) for osteoporosis in a cohort of postmenopausal women. Calcif Tissue Int. 2021;108(6):725\u201337. https:\/\/doi.org\/10.1007\/s00223-020-00802-3.","journal-title":"Calcif Tissue Int"},{"key":"834_CR120","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.16476\/j.pibb.2016.0236","volume":"43","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, Ren XZ, Wang YZ, Ma X, Zuo QL, Han JX, et al. Bioinformatics interaction analysis of Wnt1- targeting mirnas and their corresponding circrnas and target genes. Prog Biochem Biophys. 2016;43:1094\u2013101. https:\/\/doi.org\/10.16476\/j.pibb.2016.0236.","journal-title":"Prog Biochem Biophys"},{"issue":"19","key":"834_CR121","doi-asserted-by":"publisher","DOI":"10.3390\/ijms231911078","volume":"23","author":"KL Stepien","year":"2022","unstructured":"Stepien KL, Bajdak-Rusinek K, Fus-Kujawa A, Kuczmik W, Gawron K. Role of extracellular matrix and inflammation in abdominal aortic aneurysm. Int J Mol Sci. 2022;23(19):11078. https:\/\/doi.org\/10.3390\/ijms231911078.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"834_CR122","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.ejvs.2022.12.028","volume":"65","author":"S Thanigaimani","year":"2023","unstructured":"Thanigaimani S, Iyer V, Bingley J, Browne D, Phie J, Doolan D, et al. Association between serum micrornas and abdominal aortic aneurysm diagnosis and growth. Eur J Vasc Endovasc Surg. 2023;65(4):573\u201381. https:\/\/doi.org\/10.1016\/j.ejvs.2022.12.028.","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"834_CR123","doi-asserted-by":"publisher","DOI":"10.1038\/s43856-025-00892-w","volume":"5","author":"G Winski","year":"2025","unstructured":"Winski G, Chernogubova E, Busch A, Eken SM, Jin H, Liljeqvist ML, et al. Microrna-15a-5p mediates abdominal aortic aneurysm progression and serves as a potential diagnostic and prognostic circulating biomarker. Commun Med. 2025;5:218. https:\/\/doi.org\/10.1038\/s43856-025-00892-w.","journal-title":"Commun Med"},{"issue":"13","key":"834_CR124","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21134600","volume":"21","author":"E Plana","year":"2020","unstructured":"Plana E, G\u00e1lvez L, Medina P, Navarro S, Forn\u00e9s-Ferrer V, Panadero J, et al. Identification of novel microrna profiles dysregulated in plasma and tissue of abdominal aortic aneurysm patients. Int J Mol Sci. 2020;21(13):4600. https:\/\/doi.org\/10.3390\/ijms21134600.","journal-title":"Int J Mol Sci"},{"key":"834_CR125","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.avsg.2023.09.065","volume":"99","author":"KM Tasopoulou","year":"2024","unstructured":"Tasopoulou KM, Karakasiliotis I, Argyriou C, Bampali M, Tsaroucha AK, Dovrolis N, et al. Next-generation sequencing of micrornas in small abdominal aortic aneurysms: mir-24 as a biomarker. Ann Vasc Surg. 2024;99:366\u201379. https:\/\/doi.org\/10.1016\/j.avsg.2023.09.065.","journal-title":"Ann Vasc Surg"},{"issue":"19","key":"834_CR126","doi-asserted-by":"publisher","first-page":"5558","DOI":"10.7150\/thno.34463","volume":"9","author":"X He","year":"2019","unstructured":"He X, Wang S, Li M, Zhong L, Zheng H, Sun Y, et al. Long noncoding rna GAS5 induces abdominal aortic aneurysm formation by promoting smooth muscle apoptosis. Theranostics. 2019;9(19):5558\u201376. https:\/\/doi.org\/10.7150\/thno.34463.","journal-title":"Theranostics"},{"issue":"3","key":"834_CR127","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.bbrc.2017.04.096","volume":"487","author":"K Miyagawa","year":"2017","unstructured":"Miyagawa K, Ogata T, Ueyama T, Kasahara T, Nakanishi N, Naito D, et al. Loss of MURC\/Cavin-4 induces jnk and MMP-9 activity enhancement in vascular smooth muscle cells and exacerbates abdominal aortic aneurysm. Biochem Biophys Res Commun. 2017;487(3):587\u201393. https:\/\/doi.org\/10.1016\/j.bbrc.2017.04.096.","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"834_CR128","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2021.10903","volume":"22","author":"T Li","year":"2021","unstructured":"Li T, Wang T, Yan L, Ma C. Identification of potential novel biomarkers for abdominal aortic aneurysm based on comprehensive analysis of circRNA-miRNA-mRNA networks. Exp Ther Med. 2021;22(6):1468. https:\/\/doi.org\/10.3892\/etm.2021.10903.","journal-title":"Exp Ther Med"},{"issue":"1","key":"834_CR129","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s12872-020-01374-8","volume":"20","author":"M Zhou","year":"2020","unstructured":"Zhou M, Shi Z, Cai L, Li X, Ding Y, Xie T, et al. Circular RNA expression profile and its potential regulative role in human abdominal aortic aneurysm, BMC Cardiovascular Disorders. BMC Cardiovasc Disord. 2020;20(1):70. https:\/\/doi.org\/10.1186\/s12872-020-01374-8.","journal-title":"BMC Cardiovasc Disord"},{"key":"834_CR130","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1061592","volume":"13","author":"XB Wu","year":"2022","unstructured":"Wu XB, Wu YT, Guo XX, Xiang C, Chen PS, Qin W, et al. Circular RNA hsa_circ_0007990 as a blood biomarker for unruptured intracranial aneurysm with aneurysm wall enhancement. Front Immunol. 2022;13:1061592. https:\/\/doi.org\/10.3389\/fimmu.2022.1061592.","journal-title":"Front Immunol"},{"key":"834_CR131","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/nrd892","volume":"1","author":"AL Hopkins","year":"2002","unstructured":"Hopkins AL, Groom CR. The druggable genome. Nat Rev Drug Discov. 2002;1:727\u201330. https:\/\/doi.org\/10.1038\/nrd892.","journal-title":"Nat Rev Drug Discov"},{"issue":"7","key":"834_CR132","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-05075-2","volume":"13","author":"Y Zhu","year":"2022","unstructured":"Zhu Y, Zhu L, Wang X, Jin H. RNA-based therapeutics: an overview and prospectus. Cell Death Dis. 2022;13(7):644. https:\/\/doi.org\/10.1038\/s41419-022-05075-2.","journal-title":"Cell Death Dis"},{"issue":"1","key":"834_CR133","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-05554-4","volume":"22","author":"K Grillone","year":"2024","unstructured":"Grillone K, Carid\u00e0 G, Luciano F, Cordua A, Di Martino MT, Tagliaferri P, et al. A systematic review of non-coding RNA therapeutics in early clinical trials: a new perspective against cancer. J Transl Med. 2024;22(1):731. https:\/\/doi.org\/10.1186\/s12967-024-05554-4.","journal-title":"J Transl Med"},{"issue":"1","key":"834_CR134","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.pharmthera.2007.08.004","volume":"117","author":"M Yang","year":"2008","unstructured":"Yang M, Mattes J. Discovery, biology and therapeutic potential of RNA interference, microRNA and antagomirs. Pharmacol Ther. 2008;117(1):94\u2013104. https:\/\/doi.org\/10.1016\/j.pharmthera.2007.08.004.","journal-title":"Pharmacol Ther"},{"issue":"20","key":"834_CR135","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25204659","volume":"25","author":"S Ochoa","year":"2020","unstructured":"Ochoa S, Milam VT. Modified nucleic acids: expanding the capabilities of functional oligonucleotides. Molecules. 2020;25(20):4659. https:\/\/doi.org\/10.3390\/molecules25204659.","journal-title":"Molecules"},{"key":"834_CR136","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-809912-4.00017-9","author":"Z Zhang","year":"2018","unstructured":"Zhang Z, Yao Z, Zhang R. Noncoding RNA-targeted therapeutics in autoimmune diseases: from bench to bedside. Epigenet Autoimmun. 2018. https:\/\/doi.org\/10.1016\/B978-0-12-809912-4.00017-9.","journal-title":"Epigenet Autoimmun."},{"issue":"7","key":"834_CR137","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1002\/eji.200838478","volume":"38","author":"HJ Anders","year":"2008","unstructured":"Anders HJ, Krug A, Pawar RD. Molecular mimicry in innate immunity? The viral RNA recognition receptor TLR7 accelerates murine lupus. Eur J Immunol. 2008;38(7):1795\u20139. https:\/\/doi.org\/10.1002\/eji.200838478.","journal-title":"Eur J Immunol"},{"issue":"2","key":"834_CR138","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1111\/j.1365-2249.2010.04176.x","volume":"161","author":"P Lenert","year":"2010","unstructured":"Lenert P. Nucleic acid sensing receptors in systemic lupus erythematosus: development of novel DNA-and\/or RNA-like analogues for treating lupus. Clin Exp Immunol. 2010;161(2):208\u201322. https:\/\/doi.org\/10.1111\/j.1365-2249.2010.04176.x.","journal-title":"Clin Exp Immunol"},{"key":"834_CR139","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.ncrna.2025.01.004","volume":"11","author":"B Chodurska","year":"2025","unstructured":"Chodurska B, Kunej T. Long non-coding RNAs in humans: classification, genomic organization and function. Non-coding RNA Res. 2025;11:313\u201327. https:\/\/doi.org\/10.1016\/j.ncrna.2025.01.004.","journal-title":"Non-coding RNA Res"},{"key":"834_CR140","doi-asserted-by":"publisher","DOI":"10.1172\/JCI152345","author":"X Gao","year":"2022","unstructured":"Gao X, Song Y, Wu J, Lu S, Min X, Liu L, et al. Iron-dependent epigenetic modulation promotes pathogenic T cell differentiation in lupus. J Clin Investig. 2022. https:\/\/doi.org\/10.1172\/JCI152345.","journal-title":"J Clin Investig"},{"issue":"15","key":"834_CR141","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1161\/CIRCULATIONAHA.117.032184","volume":"138","author":"DY Li","year":"2018","unstructured":"Li DY, Busch A, Jin H, Chernogubova E, Pelisek J, Karlsson J, et al. H19 induces abdominal aortic aneurysm development and progression. Circulation. 2018;138(15):1551\u201368. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.117.032184.","journal-title":"Circulation"},{"issue":"1","key":"834_CR142","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1186\/s13075-019-2044-2","volume":"21","author":"J Luan","year":"2019","unstructured":"Luan J, Fu J, Chen C, Jiao C, Kong W, Zhang Y, et al. LNA-anti-miR-150 ameliorated kidney injury of lupus nephritis by inhibiting renal fibrosis and macrophage infiltration. Arthritis Res Ther. 2019;21(1):276. https:\/\/doi.org\/10.1186\/s13075-019-2044-2.","journal-title":"Arthritis Res Ther"},{"key":"834_CR143","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2024.107102","volume":"201","author":"MD P\u00e9rez-Carri\u00f3n","year":"2024","unstructured":"P\u00e9rez-Carri\u00f3n MD, Posadas I, Ce\u00f1a V. Nanoparticles and siRNA: a new era in therapeutics? Pharmacol Res. 2024;201:107102. https:\/\/doi.org\/10.1016\/j.phrs.2024.107102.","journal-title":"Pharmacol Res"},{"key":"834_CR144","doi-asserted-by":"publisher","first-page":"8627","DOI":"10.2147\/IJN.S220754","volume":"14","author":"L Diao","year":"2019","unstructured":"Diao L, Tao J, Wang Y, Hu Y, He W. Co-delivery of dihydroartemisinin and HMGB1 siRNA by TAT-modified cationic liposomes through the TLR4 signaling pathway for treatment of lupus nephritis. Int J Nanomed. 2019;14:8627\u201345. https:\/\/doi.org\/10.2147\/IJN.S220754.","journal-title":"Int J Nanomed"},{"issue":"S1","key":"834_CR145","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2004.05.061","volume":"9","author":"X Ye","year":"2004","unstructured":"Ye X, Zhu T, Li J, Xiao X. 38. AAV-mediated gene therapy for systemic lupus erythematosus (SLE). Mol Ther. 2004;9(S1):S16. https:\/\/doi.org\/10.1016\/j.ymthe.2004.05.061.","journal-title":"Mol Ther"},{"issue":"1","key":"834_CR146","doi-asserted-by":"publisher","DOI":"10.1186\/s12950-024-00381-2","volume":"21","author":"SF Samavati","year":"2024","unstructured":"Samavati SF, Yarani R, Kiani S, HoseinKhani Z, Mehrabi M, Levitte S, et al. Therapeutic potential of exosomes derived from mesenchymal stem cells for treatment of systemic lupus erythematosus. J Inflamm. 2024;21(1):20. https:\/\/doi.org\/10.1186\/s12950-024-00381-2.","journal-title":"J Inflamm"},{"issue":"4","key":"834_CR147","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1007\/s40620-020-00832-y","volume":"34","author":"J Perez-Hernandez","year":"2021","unstructured":"Perez-Hernandez J, Martinez-Arroyo O, Ortega A, Galera M, Solis-Salguero MA, Chaves FJ, et al. Urinary exosomal miR-146a as a marker of albuminuria, activity changes and disease flares in lupus nephritis. J Nephrol. 2021;34(4):1157\u201367. https:\/\/doi.org\/10.1007\/s40620-020-00832-y.","journal-title":"J Nephrol"},{"issue":"3","key":"834_CR148","doi-asserted-by":"publisher","first-page":"197","DOI":"10.23876\/j.krcp.2018.37.3.197","volume":"37","author":"M Kato","year":"2018","unstructured":"Kato M. Noncoding RNAs as therapeutic targets in early stage diabetic kidney disease. Kidney Res Clin Pract. 2018;37(3):197. https:\/\/doi.org\/10.23876\/j.krcp.2018.37.3.197.","journal-title":"Kidney Res Clin Pract"},{"issue":"4","key":"834_CR149","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1080\/09674845.2020.1765459","volume":"77","author":"MA Ali","year":"2020","unstructured":"Ali MA, Shaker OG, Khalefa AA, Abdelwahed MY, Ali EGI, Ezzat EM, et al. Serum long noncoding RNAs FAS-AS1 and PVT1 are novel biomarkers for systemic lupus erythematous. Br J Biomed Sci. 2020;77(4):208\u201312. https:\/\/doi.org\/10.1080\/09674845.2020.1765459.","journal-title":"Br J Biomed Sci"},{"issue":"10","key":"834_CR150","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1038\/s41565-022-01179-0","volume":"17","author":"M Broto","year":"2022","unstructured":"Broto M, Kaminski MM, Adrianus C, Kim N, Greensmith R, Dissanayake-Perera S, et al. Nanozyme-catalysed CRISPR assay for preamplification-free detection of non-coding RNAs. Nat Nanotechnol. 2022;17(10):1120\u20136. https:\/\/doi.org\/10.1038\/s41565-022-01179-0.","journal-title":"Nat Nanotechnol"},{"issue":"1","key":"834_CR151","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.celrep.2018.03.036","volume":"23","author":"SH Roth","year":"2018","unstructured":"Roth SH, Danan-Gotthold M, Ben-Izhak M, Rechavi G, Cohen CJ, Louzoun Y, et al. Increased RNA editing may provide a source for autoantigens in systemic lupus erythematosus. Cell Rep. 2018;23(1):50\u20137. https:\/\/doi.org\/10.1016\/j.celrep.2018.03.036.","journal-title":"Cell Rep"},{"key":"834_CR152","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/91070","volume":"28","author":"K Yasutomo","year":"2001","unstructured":"Yasutomo K, Horiuchi T, Kagami S, Tsukamoto H, Hashimura C, Urushihara M, et al. Mutation of DNASE1 in people with systemic lupus erythematosus. Nat Genet. 2001;28:313\u20134. https:\/\/doi.org\/10.1038\/91070.","journal-title":"Nat Genet"},{"key":"834_CR153","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1086\/423790","volume":"5","author":"C Kyogoku","year":"2004","unstructured":"Kyogoku C, Langefeld CD, Ortmann WA, Lee A, Selby S, Carlton VEH, et al. Genetic association of the R620W polymorphism of protein tyrosine phosphatase PTPN22 with human SLE. Am J Hum Genet. 2004;5:504\u20137. https:\/\/doi.org\/10.1086\/423790.","journal-title":"Am J Hum Genet"},{"key":"834_CR154","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1038\/sj.ejhg.5201214","volume":"12","author":"M Barreto","year":"2004","unstructured":"Barreto M, Santos E, Ferreira R, Fesel C, Fontes MF, Pereira C, et al. Evidence for CTLA4 as a susceptibility gene for systemic lupus erythematosus. Eur J Hum Genet. 2004;12:620\u20136. https:\/\/doi.org\/10.1038\/sj.ejhg.5201214.","journal-title":"Eur J Hum Genet"},{"key":"834_CR155","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1038\/nm1288","volume":"11","author":"RA Floto","year":"2005","unstructured":"Floto RA, Clatworthy MR, Heilbronn KR, Rosner DR, MacAry PA, Rankin A, et al. Loss of function of a lupus-associated Fc-gamma-RIIb polymorphism through exclusion from lipid rafts. Nat Med. 2005;11:1056\u20138. https:\/\/doi.org\/10.1038\/nm1288.","journal-title":"Nat Med"},{"key":"834_CR156","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1002\/art.40120","volume":"69","author":"L Jia","year":"2017","unstructured":"Jia L, Levine AB, Lockshin MD. American college of rheumatology criteria for systemic lupus erythematosus exclude half of all systemic lupus erythematosus patients. Arthritis Rheumatol. 2017;69:1502\u20133. https:\/\/doi.org\/10.1002\/art.40120.","journal-title":"Arthritis Rheumatol"},{"key":"834_CR157","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2018-000280","volume":"6","author":"MD Lockshin","year":"2019","unstructured":"Lockshin MD, Barbhaiya M, Izmirly P, Buyon JP, Crow MK. SLE: reconciling heterogeneity. Lupus Sci Med. 2019;6:e000280. https:\/\/doi.org\/10.1136\/lupus-2018-000280.","journal-title":"Lupus Sci Med"},{"issue":"1","key":"834_CR158","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01196-x","volume":"8","author":"Z Wei","year":"2017","unstructured":"Wei Z, Batagov AO, Schinelli S, Wang J, Wang Y, El Fatimy R, et al. Coding and noncoding landscape of extracellular RNA released by human glioma stem cells. Nat Commun. 2017;8(1):1145. https:\/\/doi.org\/10.1038\/s41467-017-01196-x.","journal-title":"Nat Commun"},{"issue":"24","key":"834_CR159","doi-asserted-by":"publisher","DOI":"10.1172\/JCI147031","volume":"131","author":"X Gong","year":"2021","unstructured":"Gong X, Tian M, Cao N, Yang P, Xu Z, Zheng S, et al. Circular RNA circEsyt2 regulates vascular smooth muscle cell remodeling via splicing regulation. J Clin Investig. 2021;131(24):e149706. https:\/\/doi.org\/10.1172\/JCI147031.","journal-title":"J Clin Investig"},{"issue":"1","key":"834_CR160","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1248\/bpb.b14-00526","volume":"38","author":"Y Hattori","year":"2015","unstructured":"Hattori Y, Hara E, Shingu Y, Minamiguchi D, Nakamura A, Arai S, et al. siRNA delivery into tumor cells by cationic cholesterol derivative-based nanoparticles and liposomes. Biol Pharm Bull. 2015;38(1):30\u20138. https:\/\/doi.org\/10.1248\/bpb.b14-00526.","journal-title":"Biol Pharm Bull"},{"key":"834_CR161","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2015.00286","volume":"6","author":"L Sercombe","year":"2015","unstructured":"Sercombe L, Veerati T, Moheimani F, Wu SY, Sood AK, Hua S. Advances and challenges of liposome assisted drug delivery. Front Pharmacol. 2015;6:286. https:\/\/doi.org\/10.3389\/fphar.2015.00286.","journal-title":"Front Pharmacol"},{"key":"834_CR162","doi-asserted-by":"publisher","first-page":"613","DOI":"10.3233\/BME-171705","volume":"28","author":"Y Amini","year":"2017","unstructured":"Amini Y, Amel Jamehdar S, Sadri K, Zare S, Musavi D, Tafaghodi M. Different methods to determine the encapsulation efficiency of protein in PLGA nanoparticles. Bio-Med Mater Eng. 2017;28:613\u201320. https:\/\/doi.org\/10.3233\/BME-171705.","journal-title":"Bio-Med Mater Eng"},{"issue":"15","key":"834_CR163","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1161\/CIRCULATIONAHA.117.032184","volume":"138","author":"DY Li","year":"2018","unstructured":"Li DY, Busch A, Jin H, Chernogubova E, Pelisek J, Karlsson J, et al. H19 induces abdominal aortic aneurysm development and progression. Circulation. 2018;138(15):1551\u201368. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.117.032184.","journal-title":"Circulation"},{"key":"834_CR164","doi-asserted-by":"publisher","first-page":"6161","DOI":"10.1039\/c5cs00199d","volume":"44","author":"M Molina","year":"2015","unstructured":"Molina M, Asadian-Birjand M, Balach J, Bergueiro J, Miceli E, Calder\u00f3n M. Stimuli-responsive nanogel composites and their application in nanomedicine. Chem Soc Rev. 2015;44:6161\u201386. https:\/\/doi.org\/10.1039\/c5cs00199d.","journal-title":"Chem Soc Rev"},{"key":"834_CR165","doi-asserted-by":"publisher","first-page":"462","DOI":"10.3390\/jcdd12120462","volume":"12","author":"E Kavaliunaite","year":"2025","unstructured":"Kavaliunaite E, Sejr Skovbo Kristensen J, Scheurer S, Berg I, Lindholt JS, Stubbe J. Therapeutic strategies for abdominal aortic aneurysm: a comprehensive systematic review. J Cardiovasc Dev Dis. 2025;12:462. https:\/\/doi.org\/10.3390\/jcdd12120462.","journal-title":"J Cardiovasc Dev Dis."},{"issue":"15","key":"834_CR166","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1042\/CS20220795","volume":"137","author":"L Puertas-Umbert","year":"2023","unstructured":"Puertas-Umbert L, Almendra-Pegueros R, Jim\u00e9nez-Altay\u00f3 F, Sirvent M, Gal\u00e1n M, Mart\u00ednez-Gonz\u00e1lez J, et al. Novel pharmacological approaches in abdominal aortic aneurysm. Clin Sci. 2023;137(15):1167\u201394. https:\/\/doi.org\/10.1042\/CS20220795.","journal-title":"Clin Sci"},{"key":"834_CR167","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2023.1324406","volume":"11","author":"P Du","year":"2024","unstructured":"Du P, Hou Y, Su C, Gao J, Yang Y, Zhang J, et al. The future for the therapeutics of abdominal aortic aneurysm: engineered nanoparticles drug delivery for abdominal aortic aneurysm. Front Bioeng Biotechnol. 2024;11:1324406. https:\/\/doi.org\/10.3389\/fbioe.2023.1324406.","journal-title":"Front Bioeng Biotechnol"},{"key":"834_CR168","doi-asserted-by":"publisher","DOI":"10.3390\/ijms262211042","volume":"26","author":"KL St\u0119pie\u0144","year":"2025","unstructured":"St\u0119pie\u0144 KL, Janas K, Rojek S. Targeting the CD47\u2013TSP1 axis in abdominal aortic aneurysm: a novel immunotherapeutic approach. Int J Mol Sci. 2025;26:11042. https:\/\/doi.org\/10.3390\/ijms262211042.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"834_CR169","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-017-1215-1","volume":"18","author":"Y Hasin","year":"2017","unstructured":"Hasin Y, Seldin M, Lusis A. Multi-omics approaches to disease. Genome Biol. 2017;18(1):83. https:\/\/doi.org\/10.1186\/s13059-017-1215-1.","journal-title":"Genome Biol"},{"key":"834_CR170","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.911861","volume":"9","author":"X Dai","year":"2022","unstructured":"Dai X, Shen L. Advances and trends in omics technology development. Front Med. 2022;9:911861. https:\/\/doi.org\/10.3389\/fmed.2022.911861.","journal-title":"Front Med"},{"issue":"1","key":"834_CR171","doi-asserted-by":"publisher","DOI":"10.1002\/wrna.1364","volume":"8","author":"R Hrdlickova","year":"2017","unstructured":"Hrdlickova R, Toloue M, Tian B. RNA\u2010Seq methods for transcriptome analysis. WIREs RNA. 2017;8(1):e1364. https:\/\/doi.org\/10.1002\/wrna.1364.","journal-title":"WIREs RNA"},{"issue":"7","key":"834_CR172","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1097\/MIB.0000000000001066","volume":"23","author":"SN Hong","year":"2017","unstructured":"Hong SN, Joung JG, Bae JS, Lee CS, Koo JS, Park SJ, et al. RNA-seq reveals transcriptomic differences in inflamed and noninflamed intestinal mucosa of Crohn\u2019s disease patients compared with normal mucosa of healthy controls. Inflamm Bowel Dis. 2017;23(7):1098\u2013108. https:\/\/doi.org\/10.1097\/MIB.0000000000001066.","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"834_CR173","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-022-01351-y","volume":"15","author":"M Nikanjam","year":"2022","unstructured":"Nikanjam M, Kato S, Kurzrock R. Liquid biopsy: current technology and clinical applications. J Hematol Oncol. 2022;15(1):131. https:\/\/doi.org\/10.1186\/s13045-022-01351-y.","journal-title":"J Hematol Oncol"},{"issue":"5","key":"834_CR174","doi-asserted-by":"publisher","DOI":"10.1002\/anbr.202000066","volume":"1","author":"M Sun","year":"2021","unstructured":"Sun M, Liu A, Yang X, Gong J, Yu M, Yao X, et al. 3D cell culture\u2014can it be as popular as 2D cell culture? Adv NanoBiomed Res. 2021;1(5):2000066. https:\/\/doi.org\/10.1002\/anbr.202000066.","journal-title":"Adv NanoBiomed Res"},{"issue":"2","key":"834_CR175","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/s41591-024-03489-3","volume":"31","author":"MM Verstegen","year":"2025","unstructured":"Verstegen MM, Coppes RP, Beghin A, De Coppi P, Gerli MF, de Graeff N, et al. Clinical applications of human organoids. Nat Med. 2025;31(2):409\u201321. https:\/\/doi.org\/10.1038\/s41591-024-03489-3.","journal-title":"Nat Med"},{"issue":"16","key":"834_CR176","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22168719","volume":"22","author":"MN Asim","year":"2021","unstructured":"Asim MN, Ibrahim MA, Imran Malik M, Dengel A, Ahmed S. Advances in computational methodologies for classification and sub-cellular locality prediction of non-coding RNAs. Int J Mol Sci. 2021;22(16):8719. https:\/\/doi.org\/10.3390\/ijms22168719.","journal-title":"Int J Mol Sci"}],"container-title":["Molecular Diagnosis & Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40291-026-00834-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40291-026-00834-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40291-026-00834-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T21:01:47Z","timestamp":1773867707000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40291-026-00834-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,16]]},"references-count":176,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["834"],"URL":"https:\/\/doi.org\/10.1007\/s40291-026-00834-9","relation":{},"ISSN":["1177-1062","1179-2000"],"issn-type":[{"value":"1177-1062","type":"print"},{"value":"1179-2000","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,16]]},"assertion":[{"value":"1 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Malwina Botor, Karolina L. St\u0119pie\u0144, Micha\u0142 Thlon and Karolina Jankowska declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Malwina Botor contributed to the conceptualization. Karolina L. St\u0119pie\u0144, Micha\u0142 Thlon and Karolina Jankowska constructed the diagrams and tables. All authors contributed to the literature investigation and manuscript preparation. All authors read and approved the final manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics declarations"}},{"value":"Not applicable","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent"}},{"value":"Not applicable","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"Data sharing not applicable to this article as no datasets were generated or analysed during the current study.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability statement"}},{"value":"The authors declare that no funds, grants, or other support were received during the preparation of this manuscript.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}}]}}